Table 1.
Baseline characteristics of the study population (n = 30).
| Parameter | Group-1 (10 g/day) |
Group-2 (20 g/day) |
Group-3 (40 g/day) |
p value |
|---|---|---|---|---|
| Number | 12 | 9 | 9 | |
| Age | 48 ± 12 (30–66) | 52 ± 18 (18–75) | 50 ± 17 (18–74) | 0.8 |
| Male/female | 8/4 | 6/3 | 6/3 | 1.0 |
| Diabetes mellitus | 41.7% | 33.3% | 55.6% | 0.6 |
| CKD stage 3B/4 | 8/4 | 3/6 | 4/5 | 0.3 |
| eGFR (mL/min/1.7 m2) | 26 ± 10 | 33 ± 11 | 29 ± 9 | 0.3 |
| Creatinine (µmol/L) | 250 ± 92 | 201 ± 78 | 216 ± 48 | 0.3 |
| BUN (mmol/L) | 14 ± 6 | 12 ± 5 | 14 ± 4 | 0.4 |
| Immunosuppression∗ | 33.3% | 22.2% | 22.2% | 0.8 |
CKD: chronic kidney disease; eGFR: estimated glomerular filtration rate; BUN: blood urea nitrogen.
∗For systemic lupus erythematosus and chronic glomerulonephritis.